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Abstract
The temporo-spatial relationship between the three organs (lung, spleen and lymph node) involved during the initial stages
of Mycobacterium tuberculosis infection has been poorly studied. As such, we performed an experimental study to evaluate
the bacillary load in each organ after aerosol or intravenous infection and developed a mathematical approach using the
data obtained in order to extract conclusions. The results showed that higher bacillary doses result in an earlier IFN-c
response, that a certain bacillary load (BL) needs to be reached to trigger the IFN-c response, and that control of the BL is
not immediate after onset of the IFN-c response, which might be a consequence of the spatial dimension. This study may
have an important impact when it comes to designing new vaccine candidates as it suggests that triggering an earlier IFN-c
response might not guarantee good infection control, and therefore that additional properties should be considered for
these candidates.
Citation: Vilaplana C, Prats C, Marzo E, Barril C, Vegue´ M, et al. (2014) To Achieve an Earlier IFN-c Response Is Not Sufficient to Control Mycobacterium tuberculosis
Infection in Mice. PLoS ONE 9(6): e100830. doi:10.1371/journal.pone.0100830
Editor: Petros C. Karakousis, Johns Hopkins University School of Medicine, United States of America
Received March 11, 2014; Accepted May 29, 2014; Published June 24, 2014
Copyright:  2014 Vilaplana et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The authors confirm that all data underlying the findings are fully available without restriction. All data are included within the manuscript.
Funding: This study was financially supported by the Spanish Government through the Plan Nacional I+D+i of the Ministerio de Ciencia e Innovacio´n CGL2010-
20160, the FIS 11/01702 and Dr Vilaplana’s Miguel Servet Contract CP13/00174. The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: P.J.C. is a PLOS ONE Editorial Board member. This does not alter the authors’ adherence to PLOS ONE Editorial policies and criteria.
* Email: pjcardona@igtp.cat
. These authors contributed equally to this work.
Introduction
The ability to subvert the host’s immune system by blocking its
ability to detect the pathogen is considered to be one of the main
characteristics of Mycobacterium tuberculosis infection [1]. Different
authors have elaborated several hypotheses to explain this
phenomenon, most of which focus on the ability of M. tuberculosis
to avoid apoptosis [2] and block antigen presentation [3,4] or
lysosomal degradation [5], amongst others. However, these
hypotheses are based on mechanisms studied at a molecular level,
thus meaning that the holistic point of view has been somewhat
overlooked [6]. Indeed, the role of lymphoid organs as the targets
of infection, the blood and lymphatic circulation, or the intrinsic
anatomy of the lung (the key organ in this infection) have been
little studied or ignored.
SChackerian [7] and Wolf [8] arrived at the same conclusion,
namely that the most important event for achieving early
control is fast infection of the hilar lymph node (as production
of specific lymphocytes is induced earlier), using two different
experimental models of TB (in mice and macaques). In contrast,
Bru and Cardona [9] arrived at a slightly different conclusion
using virtual models, namely that although the time at which
the immune response is triggered is important, the local
production of chemokines which can attract those lymphocytes
to activate the infected macrophages is equally important. This
supported the idea of granuloma formation being necessary as a
tool for controlling the infection by making the infectious focus
‘‘visible’’ to the specific lymphocytes [10], in contrast to the
proposal that the granuloma could be a ‘‘foe’’ by allowing the
bacilli to persist [11]. Observations from other researchers [Ian
Orme, personal communication] and our group [9,12] also
support the beneficial role of the granuloma. Thus, no lesions
can be seen in the lung during the first two weeks of a low dose
aerosol infection despite the global bacillary load (BL) increasing
from 102 to 105, thereby indirectly demonstrating a ‘‘hidden’’
initial phase of the infection [6]. This unicellular infection phase
appears to last about 10–15 days [9,13] and coincides with the
time need to detect the first granulomas [7,8,14]. During this
period, M. tuberculosis grows inside individual infected macro-
phages that cannot be detected by specific lymphocytes,
probably because they are not able to produce sufficient
chemokines to attract them. The existence of this phase could
also support previous and recent results claiming the detection
of bacilli in healthy tissue [15,16].
In order to study the temporo-spatial relationship between the
three organs (lung, spleen and lymph node) involved during initial
M. tuberculosis infection, we designed an experimental study in
which mice were infected via aerosol (AER) or endovenously (EV)
and consequently followed-up, subsequently developing a math-
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ematical approach to reproduce the results obtained experimen-
tally and to extract conclusions.
Results
Higher Bacillary Doses Trigger an Earlier IFN-c Response
For consensus, and taking into account the experimental
results, we considered 20 SFU/250,000 cells to be the threshold
for onset of the specific IFN-c response. This value was chosen
because, whenever a significant change was detected in the
ELISPOT results, it always meant that this value had been
exceeded. In the EV model, the immune response was first
detected in the spleen in all cases (Table 1). A comparison
between the specific responses shows how the immunity mainly
targets ESAT-6. At the highest dose (105 CFU/ml), specific
lymphocytes are detected first in the lung and then in the
lymph node, thus reflecting the accumulation of circulating
IFN-c producing lymphocytes from the spleen before immune
specific IFN-c response is triggered in the lymph nodes. This
suggests that some degree of BL is needed for the induction of
immunity. In the EV model, higher challenge doses lead to
earlier IFN-c responses.
In contrast, there is no difference as regards onset of the IFN-c
response among the organs in the aerosol model: it appears at the
same time in all of them.
A Specific Bacillary Load Must Be Reached to Trigger the
IFN-c Response
Considering the minimum time required to trigger the IFN-c
response obtained from the highest challenge model (105), we
estimated the delay between this trigger and onset of the IFN-c
response to be 2.5 days. In light of this value, we evaluated the BL
threshold required to trigger the IFN-c response by analysing the
level thereof 2.5 days prior to onset of the IFN-c response in each
experimental model. Specifically, in each case we determined
which organ had the highest BL 2.5 days before the onset (i.e.,
which the triggering organ was) and which this threshold value
was. The results showed that the BL level required is relatively
constant, at around 3.5 log10 (Table 2). This threshold is exceeded
from the beginning in the highest dose EV model, thus validating
the hypothesis used in these estimations (i.e., that the 105 dose is
enough for triggering the IFN-c response immediately after
infection).
Control of the BL Is Not Immediate After Onset of the
IFN-c Response
Figure 1 shows the evolution of the BL in the different organs as
obtained in the experimental in vivo models (in black). After the EV
challenge, the IFN-c response was estimated to appear at days 2.5
(initial inoculum =105), 6.47 (104) and 11.77 (102) (Table 2); BL
control occurs subsequently. The sooner the IFN-c response is
triggered, the sooner BL control occurs, at least in spleen and LN.
This effect is not seen in lungs. Table 3 shows the delay between
the appearance of the IFN-c response and the effective control of
the BL, per organ.
The BL in an organ does not appear to be crucial as regards the
control of bacillary growth, as this occurs over a wide range from
105 to 107 CFU/ml depending on the initial infective dose.
In the aerosol-infected model, BL control in the lung, which is
the organ with the highest bulk, appears at the same time as the
immune response. However, and as is the case for the EV model,
BL control in the spleen is achieved 5 days after the onset of the
IFN-c response (i.e. at day 16.43). This value confirms that,
although a low BL in the spleen is able to trigger and attract the
IFN-c response, it is not capable of effectively stopping bacillary
growth.
The Mathematical Model Designed Reproduces the
Experimental Data and Highlights the Importance of
Considering the Spatial Factor
The in silico model built provided results which agreed well with
experimental measurements in terms of time and levels (Figure 1).
104 and 105 series were used for parameter estimation (i.e., for
fitting the model to experimental data), and 102 and AER series
where used for validation of the model. However, BL control was
achieved earlier in the mathematical model than in the in vivo
models under all conditions.
Discussion
The aim of this study was to evaluate the bacillary load and
specific IFN-c responses in lung, spleen and lymph node, after
Table 1. Detection of PPD-specific IFN-c response.
DETECTION PPD-SPECIFIC IFN-c RESPONSE (in days)
EV exp (depending on the inoculum, in CFU)
ORGAN 102 104 105
spleen 14 8 5
lymph node 20 17 11
lung $28 20 8
DETECTION ESAT-6-SPECIFIC IFN-c RESPONSE (in days)
EV exp (depending on the inoculum, in CFU)
ORGAN 102 104 105
spleen 14 8 5
lymph node 11 14 11
lung 20 17 8
Day of detection of the PPD- and ESAT-6-specific IFN-c responses in the three different organs obtained for all experiments performed.
doi:10.1371/journal.pone.0100830.t001
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aerosol or intravenous infection; and to develop a mathematical
approach with the data obtained.
To date, a paramount role has been assigned to rapid infection
of the lung lymph node as regards onset of the immune response
and better infection control in the lung [7,8]. The results showed
that a critical BL has to be reached to trigger the immune
responses (at least in terms of IFN-c responses) and that as highest
is the BL the earlier this response is triggered, and yet
(paradoxically) it is not sufficient to stop immediately the BL
growth.
The dual role of lymph nodes and spleen as providers of
effector immune cells and as infectious foci intrigued us, and
anatomy is one of the possible answers. An infected macrophage
or dendritic cell could reach the trabecular sinuses, thereby
initiating infection of the lymph node in an anatomically
different location in the cortex or the medullar sinus, where
antigens are presented to B and T cells, respectively [17]. If this
is the case, local infection in the lymphoid tissues would not be
directly controlled by the local IFN-c response triggered, which
will be spilled to the efferent capillary lymph vessels and
therefore to pulmonary circulation thus to the right heart and
lungs [18], where it is attracted and further captured by
pulmonary infectious sites. Likewise, the spleen, which special-
izes in retaining and destroying old erythrocytes [19], has two
compartments: the red pulp, where an infection is more likely to
occur, and the white pulp, in which the antigens are presented
and specific lymphocyte proliferation induced [19].
SOur initial hypothesis was that this was possible because
lymphatic organs could host an infected site while still being
able to develop a specific IFN-c response against this infection
(although not benefiting from it) for anatomical reasons. Indeed,
the results of our mathematical model support this. Because of
the anatomy of lymphatic tissues, the lymphocytes would follow
the lymphatic and blood circulation and be further attracted by
other infectious foci. In the case of a low dose aerosol at day 21
post-infection, when the bacillary load in the lung is very high,
a lymphocyte generated in the spleen will reach the cava vein
and then progress further to the right atrium and right
ventricle, eventually reaching the lung. At this point, because
of the high infection, the lesions are likely to attract this
lymphocyte. If this does not occur, it will continue into the left
atrium and ventricle to circulate throughout the rest of the
body, perhaps being attracted by the infected lymph nodes or
even reaching the spleen. This dynamic was validated by the
mathematical model.
Interestingly enough, even in this situation it is not clear
whether these lymphocytes will be able to activate the infected
macrophages, as a pool of attraction (i.e. a local focus of
chemokine production) is needed, suggesting the granuloma
allows the attraction of specific lymphocytes [10]. Considering
that the initial infection usually takes place inside the alveolar
macrophage (in the alveolar space), where immunological
surveillance is almost impossible, favoring reinfection, the lack
of pool of attraction is a problem in terms of infection control
in this timeframe [9,20].
We are aware that the host immune response against
tuberculosis involves a complex combination of cytokines,
chemokines and signaling molecules other than the IFN-c
responses, and our study was only focused on PPD and ESAT-6
specific IFN-c responses. However, as these have been widely used
as a marker of tuberculosis infection even if its limitations are
commonly known and accepted, we did considered that they could
fairly be representative of the host immune response for the study
purposes. Moreover, the number of animals involved was also
relevant for this decision, as to add more essays to explore other
would have meant to increase this number in detrimental of ethics.
On the other hand, we tried to keep the parameters and premises
of the in silico model at minimum, in order to keep it as simple as
possible.
Another limitation of our study is that it is based on an
experimental mice model, and mice are far from humans.
However, in terms of anatomy of the organs studied and dynamics
of blood circulation, the results obtained in mice can be totally
extrapolated to humans, at least those related with the qualitative
dynamics. The quantitative results (for instance, the delay between
trigger and onset of IFN-c response, or the BL threshold for such
triggering) may slightly change from mice to human, and thus the
mathematical model should be specifically parameterized for the
second case.
Table 2. Onset of the specific IFN-c response.
APPEARANCE OF THE SPECIFIC IFN-c RESPONSE
EV exp (depending on the inoculum, in CFU) AER exp
102 104 105
Organ of appearance of the
specific IFN-c response (.20 SFU)
and day of appearance
of such response
spleen spleen spleen spleen and lymph node
11.760.4 days 6.460.9 days 2.560.5 days 16.462.3 days
Organ that triggers the
specific IFN-c response
and its BL 2.5 days before
appearing the specific IFN-c
response
spleen spleen spleen lymph node
3.4160.21 log CFU 3.7760.17 log CFU 4.6660.14 log CFU ,3.6160.23 log CFU
First row: estimated onset of the specific IFN-c response taking into account the organ and day on which it appears. The moment at which the 20 SFU threshold would
have been surpassed is linearly interpolated between two consecutive experimental points (last point with SFU,20 and first point with SFU.20). Second row: organ
and BL of the organ that would have triggered the IFN-c response 2.5 days before its estimated appearance (i.e., organ with the highest BL at that moment).
doi:10.1371/journal.pone.0100830.t002
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The mathematical model designed to simulate the complex
anatomical relationships between the different infected organs
reproduces the general dynamics of the experimental results. As
in the generation of any other in silico model, assumptions have
to been made and the parameters chosen, something we did
trying to keep it simple and in accord with experimental
observations. The only point where it differs from them is on
the delay on controlling the BL, as it only takes into account
the global BL of each one without considering the local
organization of the infected cells, and cannot incorporate the
spatial dimension which might be important for attracting
specific lymphocytes to each infectious focus. This may be the
reason why faster control of the BL is achieved after onset of
the IFN-c response than in the in vivo model, therefore showing
the importance of this factor.
In conclusion, although lymphoid organs appear to be
organized as a two compartment structures, thus favoring infection
control in non-lymphoid organs, the the local attraction of specific
lymphocytes to the infected sites is crucial as regards controlling
the BL in these organs and on the infection control.
Overall, these data suggest that the key to subversion of the
immune response by M. tuberculosis is not related to the ability of
the bacilli to slow its induction. Indeed, our findings show that the
speed of the immune response is not related to the degree of
infection control as the ability of infected cells to attract specific
lymphocytes appears to be the most critical factor as regards
Figure 1. Output of the in silico model and the corresponding experimental results. The output of the in silico model (white symbols) are
represented considering EV infections of 102, 104 and 105 CFU/mL and an AER infection. The experimental results are represented by black symbols.
The results are shown individually for each organ (lungs (circles), spleen (squares) and lymph node (triangles)). Ten repetitions of each simulation
were performed by changing the random seed. Each experimental point corresponds to an individual mouse.
doi:10.1371/journal.pone.0100830.g001
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benefitting from the immune response, at least in terms of IFN-c
responses.
This might have a conceptual impact when it comes to
designing new prophylactic strategies, especially new vaccine
candidates as, if they are able to trigger a rapid IFN-c response
(or even -if we hypothesize- a rapid Th1 immune response), will
this be sufficient to cope with the infection? The answer to this
is probably not, as this enhanced IFN-c response will not know
where to act as no infectious foci will be generating sufficiently
strong attractive signals. In light of the results of our study, we
therefore suggest that other strategies focusing on therapeutic
vaccines or those generating humoral responses, for example,
should perhaps be explored.
Materials and Methods
Experimental Data
Mice. 6–8-Week-old female C57BL/6 specific-pathogen-free
(spf) mice were obtained from Harlan Laboratories (Sant Feliu de
Codines, Catalonia, Spain). The animals were shipped under
suitable conditions, with the corresponding certificate of health
and origin. Upon arrival, the mice were kept under controlled
conditions in a P3 high security facility with sterile food and water
‘‘ad libitum’’.
Ethics. All animal procedures were approved and supervised
by the Animal Care Committee of the Germans Trias i Pujol
University Hospital and by the Department of Environment of the
Catalan Government. Mice were weighed and checked every week
following a protocol that monitored weight loss, apparent good
health (bristled hair and wounded skin) and behaviour (signs of
aggressiveness or isolation). Mice were euthanized with isoflurane
(inhalation excess) in all cases in order to avoid any suffering.
Experimental plan. Two routes of infection were evaluated:
the aerosol and the intravenous route. A total of six animals per
experimental group were included in each experiment. The AER
experiment was run twice, whereas the EV experiment was run
only once due to the already high number of mice involved for the
three different inoculation doses being evaluated (102, 104 or 105
Colony Forming Units (CFU) per mL).
The animals were sacrificed at established sequential time-
points. Different timepoints were established for AER and the EV
exp based on our previous experience with experimental TB
infection. In the aerosol experiment, animals were sacrificed on
each day from day 10 to 22 post-infection, whereas in the EV
experiment mice were sacrificed on days 0 and 2, 5, 8, 11, 14, 17,
20, 28 and 42 post-infection.
Infection. M. tuberculosis strain H37Rv Pasteur was grown in
Proskauer Beck medium. In the AER experiment, animals were
placed in the exposure chamber of an airborne infection apparatus
(Glas-col Inc., Terre Haute, IN, USA) for infection with a low dose
of M. tuberculosis. Nebulization provided an approximate uptake of
20–50 bacilli by mice lungs.
In the EV experiment, a total volume of 0.2 mL containing 102,
104 or 105 CFU per mL (depending on the experimental group)
was inoculated into the tail vein of each mouse.
Evaluation of the infection. The bacillary load (BL) and
specific IFN-c responses measured were the parameters chosen to
evaluate the infection. Both parameters were measured in lung,
spleen and lymph nodes, which were extracted and mechanically
disrupted in order to obtain tissue homogenates. Lymph nodes
samples could occasionally not be harvested at the earliest
timepoints as they were too small to be readily recognised,
therefore no results were recorded in such cases.
The BL was determined by culturing the samples on
Middlebrook 7H11 agar plates (Bennex Ltd, Shannon, Ireland)
at 37uC for 21 days. Visible colony forming units (CFU) were
counted four weeks later, with data being recorded as the log of the
total number of CFUs recovered per organ.
Table 3. Delays between the appearance of the IFN-c response and the effective control of the BL, per challenge dose and route,
and per organ.
Spleen Lymph node Lungs
EV exp 102
Day of estimated appearence of the IFN-c response (1) 11,7 - -
Day of detected control of BL 17 17 14
Delay between appearence of the IFN-c response and BL control (days) 5,3 5,3 2,3
EV exp 104
Day of estimated appearence of the IFN-c response (1) 6,4 - -
Day of detected control of BL 14 14 11
Delay between appearence of the IFN-c response and BL control (days) 7,6 7,6 4,6
EV exp 105
Day of estimated appearence of the IFN-c response (1) 2,5 - -
Day of detected control of BL 11 11 14
Delay between appearence of the IFN-c response and BL control (days) 8,5 8,5 11,5
AER exp
Day of estimated appearence of the IFN-c response (1) 16,4 - 16,4
Day of detected control of BL 21 21 16
Delay between appearence of the IFN-c response and BL control (days) 4,6 4,6 <0
(1) Deviations shown in Table 2
These delays are evaluated by subtraction between the day when BL control is experimentally detected at each organ and the day of the estimated appearance of IFN-c
response.
doi:10.1371/journal.pone.0100830.t003
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Specific cellular IFN-c responses against the antigens ESAT-6
(Lionex Diagnostics & Therapeutics, Braunschweig, Germany),
which was used at a final concentration of 5 mg/mL, and PPD
(Statens Serum Institute, Kobenhavn, Denmark), which was used
at a final concentration of 10 mg/mL, were measured using an
IFN-c ELISPOT kit (BD Bioscience, San Diego, CA) after plating
250,000 cells from the tissue homogenates. The ELISPOT assay
was further developed and read according to the manufacturer’s
instructions. The results were expressed as IFN-c secreting cells as
Spot Forming Units (SFU) per 250,000 cells.
The In Silico Model
An in silicomodel based on several premises was designed in order
to test our hypothesis regarding the in vivo dynamics of the infection.
It was fitted to and validated with experimental results and
subsequently further used to extract some conclusions about how
the flows between the different organs influence the infection. In
order to build this model, different variables, processes and
parameters were taken into account. These are described below (S1).
Model Variables
Those quantities that vary with time and represent the dynamics
of the system were termed variables. According to the experi-
mental measurements, these variables are the BL and the level of
IFN-c response expressed as IR.
BLl(t), BLs(t) and BLln(t) are the bacillary loads in lung, spleen and
lymph nodes at time t, respectively, and IRl(t), IRs(t) and IRln(t) the
immune responses in lung, spleen and lymph nodes at the same time
t, respectively. The dynamics of these variables are governed by the
model processes described below. The output of the model should
agree with the experimental behavior of these variables.
Model Processes
The model processes are those that can make the variables
change, and are based on assumptions decided by consensus after
checking different possibilities and their effects on the model
output, that should be in accord with experimental data. Three
such processes were considered: local bacillary growth, the trigger
for the specific immune response and the flows between the three
different organs studied.
Local bacillary growth. In order to model the bacillary
growth in each organ (lung, spleen and lymph nodes), the effective
net growth arising from replication inside macrophages and
bacterial death was taken into account. This growth, which is
represented by the classic logistic model, is modulated by the IFN-
c response activity (aIR) as follows (Eq. 1).
dBLi
dt
~m:max
0,BLi(t){aIR:IRi(t)ð Þ: 1{ BLi(t)
BLmax:Vi
 
i~l,s, ln
ð1Þ
Thus, Eq. (1) shows the time (t) evolution of BL at each organ (l
for lungs, s for spleen and ln for lymph nodes), as modulated by the
IFN-cresponse level (IR) in the corresponding organ (i = l, s, ln).
The parameters involved are the bacillary effective growth rate (m),
the maximum bacillary load per unit volume (BLmax), the effective
organ volumes (Vi, i = l, s, ln), and the IFN-c response activity
(aIR). The latter represents the number of bacilli that are
inactivated per unit of specific IFN-c response.
Bacillary flows between organs. The bacilli grow locally in
each organ but can be released into circulation and reach another
organ. This is thought to occur after the lysis of infected
macrophages, when bacilli are released into the extracellular
environment. As such, migration of bacilli from one organ to
another is linked to the discrete intervals at which macrophages
burst. Consequently, this process is modelled as discrete migrations
at certain time intervals corresponding to multiples of Tlysis after
initial infection of the corresponding organ rather than as a
constant flow. The parameter Tlysis represents the mean time that
a macrophage takes to burst once infected.
The physiological flows (determined by the blood circulation
dynamics) important (i.e., numerically relevant to the results) for
the dynamics of the model were chosen according to the
principle of Occam’s razor [21]. That is, all such flows were
initially incorporated into the model but only those that were
numerically relevant were kept. In the EV case, initial
concentrations in the spleen and lungs were similar. If lungs
were not initially infected (low concentration), infection came
from the spleen. Some of the bacilli coming from the spleen
could not be detained in the lungs and arrived directly at the
lymph nodes without being previously phagocytosed by an
alveolar macrophage. In the AER case, the main flow was from
lungs to lymph nodes and then on to the spleen. Table 4 shows
the flows between organs considered.
Macrophage lysis can be considered to be a synchronic
phenomenon at the beginning of the infection (i.e., infected
macrophages burst approximately simultaneously), although it
becomes desynchronized as time goes by. As such, bacillary
migration should be considered to be discrete at the beginning
of the infection and as continuous at some point thereafter.
However, this phenomenon is only significant at the beginning
of the infection as, when the bacillary load is high, the
migratory effect between organs becomes irrelevant.
Trigger and dynamics of the specific IFN-c
response. The experimental results for the EV experiment show
that the IR depends on the inoculated dose and, therefore, that it
should also depend on the bacillary load: while BL remains small,
no IR would be activated. Once a certain threshold is surpassed, an
IR would be triggered. Another important experimental observa-
tion is that although very high inoculated doses (105 CFU/mL)
should be sufficient to activate the IR, IR measurements take some
time to become positive. This suggests that, once the IR is triggered,
there is some delay until it appears. These two observations are
incorporated into the model using the parameters BLthres and Tdelay,
which represent the BL threshold to trigger the IR and the time
delay for the detection of this response, respectively.
Once the IR is activated and generated in a lymphatic organ,
lymphocytes are thought to enter the blood stream in order to
reach the infected organs. As such, the model should consider the
specific IR level in blood (IRblood) as an auxiliary variable. This
variable increases with lymphocyte production at the rate c, driven
by BLthres and Tdelay, and decreases due to lymphocyte lysis (with a
rate v) or when the lymphocytes are retained by an infected organ,
as shown by Eq (2).
dIRblood(t)
dt
~Hi BLi(t{Tdelay)
 
:ci{IRblood (t)
:v{
X
j~l,s, ln
dIRj(t)
dt
with Hi(x)~
0 if xvBLthres
1 if x§BLthres
( )
and i~s, ln
ð2Þ
An Earlier IFN-c Response, Not Sufficient to Control M.tuberculosis
PLOS ONE | www.plosone.org 6 June 2014 | Volume 9 | Issue 6 | e100830
The retention of an IR by an infected organ is assumed to
depend on the bacilli growing in that organ (i.e., it does not
depend on the bacillary load of the organ, BLi(t), but on BLi(t)-
aIR?IRi(t), as shown in Eq (1)). Other parameters involved in
lymphocyte transport include the blood flow Fblood (volume of
blood that enters the left ventricle of mouse heart per unit time)
and the fraction of this flow that enters each of the organs
considered (Qi with i = l, s, ln). Eq (3) shows the equation for the
model governing lymphocyte transport to these organs.
dIRi
dt
~IRblood (t):Fblood :Qi:
Max(0,BLi(t){aIR:IRi(t))
BLmax:Vi
i~l,s, ln
ð3Þ
The model presented above for the dynamics of the IR is
extremely simple but attempts to represent the overall dynamics of
IR by taking into account the most relevant processes.
Parameter Estimation
Parameters are those quantities that determine the result of the
processes studied, for instance, the effective bacillary growth rate
(m). Their values must be directly extracted or estimated from
experimental data and the literature or, in the worst case, inferred
by fitting the model output to experimental results. Table 4 shows
the list of parameters of the model, as well as their values and how
these values have been fixed.
The duplication time was set to 24 hours, which is in
accordance with the literature [22] and corresponds to a specific
growth rate of 0.029 h21. This value is compatible with the
absolute maximum apparent growth rate observed experimen-
tally, in particular in the EV experiment with low inoculum (102
CFU/mL) in spleen. In these measurements, if we consider the
interval between days 2 and 10 (Fig. 1) we obtain a duplication
time of 1.39 days (R2 = 0.999). This value apparently shows a
slower growth but is distorted by local factors such as bacillary
flows. The parameters Tdelay and BLthres were inferred from
experimental measurements, as detailed in Section 2.2. The
extinction rate of specific lymphocytes (v) was estimated using
the expression v= ln2/t1/2, where t1/2 is the time at which the
specific IFN-c response is reduced to half of its maximum value.
Reference [9] provides an order of magnitude of 3 hours for
this value, which is in accordance with the half-life of specific
lymphocytes in the absence of antigens. The percentage of
blood that enters each organ, Qi, was chosen on the basis of the
irrigation for each organ.
Finally, the remaining parameters were estimated by fitting the
model simulation results to EV experimental results for inocula of
104 and 105 CFU/mL, only. To do so, an objective function was
defined (Eq. 4):
f (BL)~
X
1ƒkƒN
DBLmod(tk){BLexp(tk)BLexp(tk) Dlung
zDBLmod(tk){BLexp(tk)BLexp(tk) Dspleen
zDBLmod(tk){BLexp(tk)BLexp(tk) Dlymph
node
0
BBBBBBBBBBBBB@
1
CCCCCCCCCCCCCA
ð4Þ
The model was implemented in the computing language C++ in
order to solve those equations that had no analytical solution,
which were solved using Euler’s numerical method (controlling the
instabilities). An exhaustive search of the set of parameters that
minimized this objective function was performed in order to
minimize differences between model output (mod) and experi-
mental measurements (exp). To do so, two series of simulations of
the mathematical model were performed, one for each initial
concentration. Each series of simulations consisted of several
repetitions with the same initial conditions, changing the random
seed in order to reproduce experimental variability.
The initial bacillary load values were taken from experimental
measurements by extrapolating data from day 2. These values
were BLl (0) = 10 CFU, BLs (0) = 270 CFU and BLln (0) = 1 CFU
for the former and BLl (0) = 2500 CFU, BLs (0) = 11000 CFU and
BLln (0) = 10 CFU for the later. The outputs obtained from the
model are shown in Figure 1. As can be observed, the initial
increase of infection in several organs and the plateau once the
specific IFN-c response is activated are well reproduced. The best
values for the parameters estimated are shown in Table 4.
Model Validation
A second set of simulations was performed using the parameters
estimated in the previous series. In this case only the initial
conditions were modified in an attempt to reproduce AER and
low concentration EV experiments without varying the model
parameters. The initial infections were fixed as 10 bacilli in lungs
(AER) and 5 bacilli in spleen (low concentration EV) with the same
Table 4. In silico model of bacillary migration between organs, where BLi(t) is the bacillary load in spleen (i = s), lungs (i = l) and
lymph nodes (i = ln) at time t.
Bacilli flow Mathematical expression
Spleen (s) to
lungs (l)
BL1 tð Þ/BL1 tð ÞzfS?l if t{tinf ,s
 
modTlyses~0
Spleen to
lymph nodes (ln)
BLln tð Þ/BLln tð ÞzfS?lnif t{tinf ,s
 
modTlyses~0
Lungs to
lymph nodes
BLln tð Þ/BLln tð Þzfl?lnif t{tinf ,1
 
modTlyses~0
Lymph
nodes to spleen
BLs tð Þ/BLs tð Þzfln?sif t{tinf ,1n
 
modTlyses~0
The auxiliary variables tinf,s, tinf,l and tinf,ln represent the time that spleen, lungs and lymph nodes have been infected. The parameters involved are detailed in Table S1.
doi:10.1371/journal.pone.0100830.t004
An Earlier IFN-c Response, Not Sufficient to Control M.tuberculosis
PLOS ONE | www.plosone.org 7 June 2014 | Volume 9 | Issue 6 | e100830
extrapolation method (see previous section). As shown in Figure 1,
the model results were in agreement with experimental measure-
ments. In the AER case, the coincidence between model and
experimental results is high, although a slight underestimation of
the plateau values can be observed. The low concentration EV
simulations reproduce the infection evolution in spleen and the
high variability of measurements in lungs and lymph nodes, which
is also in agreement with experimental results.
The underestimation of the plateaus seen in most of the
simulations suggests that although the model considers the effect of
the specific IFN-c response to be immediate, this might not be the
case in vivo (as already suggested by the experimental results).
Supporting Information
Table S1 Parameters of the in silico model. The
Parameters of the in silico model described in Equations (1), (2)
and (3) and in Table 3 have been included in this table, as well as
their description, source and values.
(PDF)
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